The effect of Proprotein convertase subtilisin/kexin type 9 inhibition on sterol absorption markers in a cohort of real-world patients

EJ Brandt, LB Benes, L Lee… - Journal of …, 2019 - journals.sagepub.com
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in multiple
tissues, including the small intestine. The effect of PCSK9 inhibition on cholesterol …

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients

EJ Brandt, LB Benes, L Lee… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in multiple
tissues, including the small intestine. The effect of PCSK9 inhibition on cholesterol …

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients.

EJ Brandt, LB Benes, L Lee, TD Dayspring… - Journal of …, 2018 - europepmc.org
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption
Markers in a Cohort of Real-World Patients. - Abstract - Europe PMC Sign in | Create an account …

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Sterol Absorption Markers in a Cohort of Real-World Patients

EJ Brandt, LB Benes, L Lee… - Journal of …, 2019 - scholars.northwestern.edu
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in multiple
tissues, including the small intestine. The effect of PCSK9 inhibition on cholesterol …